Correction: The dual PI3K/mTOR inhibitor dactolisib elicits antitumor activity in vitro and in vivo [Oncotarget. 9, (2018) (706-717)] doi: 10.18632/oncotarget.23091
机构:[1]Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China[2]Institute of Basic Medicine Science, Chinese PLA General Hospital, Beijing 100853, China[3]Key Laboratory of Cancer Center, Chinese PLA General Hospital, Beijing 100853, China[4]Department of Anesthesiology, Wuxi Third People’s Hospital, Wuxi, Jiangsu 214000, China[5]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China神经外科首都医科大学宣武医院
第一作者机构:[1]Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Neurosurgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200000, China[5]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
Fei Shi,Jinying Zhang,Hongyu Liu,et al.Correction: The dual PI3K/mTOR inhibitor dactolisib elicits antitumor activity in vitro and in vivo [Oncotarget. 9, (2018) (706-717)] doi: 10.18632/oncotarget.23091[J].Oncotarget.2018,9(24):17255.doi:10.18632/oncotarget.25063.
APA:
Fei Shi,Jinying Zhang,Hongyu Liu,Liangliang Wu,Hongyu Jiang...&Hao Wu.(2018).Correction: The dual PI3K/mTOR inhibitor dactolisib elicits antitumor activity in vitro and in vivo [Oncotarget. 9, (2018) (706-717)] doi: 10.18632/oncotarget.23091.Oncotarget,9,(24)
MLA:
Fei Shi,et al."Correction: The dual PI3K/mTOR inhibitor dactolisib elicits antitumor activity in vitro and in vivo [Oncotarget. 9, (2018) (706-717)] doi: 10.18632/oncotarget.23091".Oncotarget 9..24(2018):17255